Name Development Level Target Family
Ig epsilon chain C region Tclin Non-IDG
Histamine H1 receptor Tclin GPCR
Name Description
omalizumab An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
omalizumab